4//SEC Filing
Goodman Jay Lawrence 4
Accession 0001213900-25-016197
CIK 0001690080other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 6:27 PM ET
Size
5.3 KB
Accession
0001213900-25-016197
Insider Transaction Report
Form 4
Goodman Jay Lawrence
Director
Transactions
- Award
Common Stock
2025-02-20+65,000→ 65,000 total
Footnotes (2)
- [F1]Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of July 1, 2025 and December 31, 2025, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3.
- [F2]Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0002042496
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 6:27 PM ET
- Size
- 5.3 KB